Chengdu Kanghong Pharmaceuticals Group Co Ltd Cash Flow Conversion Efficiency
Chengdu Kanghong Pharmaceuticals Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥504.02 Million ≈ $73.75 Million USD) by net assets (CN¥9.15 Billion ≈ $1.34 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
Cash flow conversion efficiency of Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2009 to 2025. This chart illustrates how Chengdu Kanghong Pharmaceuticals Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002773 stock price for real-time trading data and today's change.
Chengdu Kanghong Pharmaceuticals Group Co Ltd Cash Flow Conversion Ratio Explained
Chengdu Kanghong Pharmaceuticals Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Chengdu Kanghong Pharmaceuticals Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chengdu Kanghong Pharmaceuticals Group Co Ltd ranked by their cash flow conversion efficiency. Also see 002773 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FIBI Holdings Ltd
TA:FIBIH
|
-0.119x |
|
Hesai Group Sponsored ADR
NASDAQ:HSAI
|
-0.004x |
|
Remitly Global Inc
NASDAQ:RELY
|
0.002x |
|
Welspun Living Limited
NSE:WELSPUNLIV
|
N/A |
|
Acadia Realty Trust
NYSE:AKR
|
0.022x |
|
Wanda Cinema Line Corp
SHE:002739
|
0.065x |
|
Guangzhou Haozhi Industrial Co Ltd
SHE:300503
|
0.011x |
|
Shanghai Bairun Flavor & Fragrance Co Ltd
SHE:002568
|
0.054x |
Annual Cash Flow Conversion Efficiency for Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
The table below shows the annual cash flow conversion efficiency of Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2009 to 2025. Review Chengdu Kanghong Pharmaceuticals Group C free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥9.27 Billion ≈ $1.36 Billion |
CN¥1.50 Billion ≈ $220.03 Million |
0.162x | -0.71% |
| 2024-12-31 | CN¥8.65 Billion ≈ $1.27 Billion |
CN¥1.41 Billion ≈ $206.60 Million |
0.163x | +4.69% |
| 2023-12-31 | CN¥7.81 Billion ≈ $1.14 Billion |
CN¥1.22 Billion ≈ $178.29 Million |
0.156x | +16.44% |
| 2022-12-31 | CN¥6.91 Billion ≈ $1.01 Billion |
CN¥925.15 Million ≈ $135.38 Million |
0.134x | +65.50% |
| 2021-12-31 | CN¥6.10 Billion ≈ $893.35 Million |
CN¥494.11 Million ≈ $72.30 Million |
0.081x | +70.45% |
| 2020-12-31 | CN¥5.76 Billion ≈ $842.26 Million |
CN¥273.32 Million ≈ $39.99 Million |
0.047x | -72.98% |
| 2019-12-31 | CN¥4.62 Billion ≈ $676.13 Million |
CN¥812.15 Million ≈ $118.84 Million |
0.176x | +104.58% |
| 2018-12-31 | CN¥4.08 Billion ≈ $597.61 Million |
CN¥350.88 Million ≈ $51.35 Million |
0.086x | -60.30% |
| 2017-12-31 | CN¥3.54 Billion ≈ $518.52 Million |
CN¥766.86 Million ≈ $112.22 Million |
0.216x | -25.72% |
| 2016-12-31 | CN¥2.90 Billion ≈ $425.08 Million |
CN¥846.35 Million ≈ $123.85 Million |
0.291x | +52.64% |
| 2015-12-31 | CN¥2.52 Billion ≈ $369.49 Million |
CN¥481.97 Million ≈ $70.53 Million |
0.191x | +5.59% |
| 2014-12-31 | CN¥1.61 Billion ≈ $235.85 Million |
CN¥291.38 Million ≈ $42.64 Million |
0.181x | -24.65% |
| 2013-12-31 | CN¥1.39 Billion ≈ $203.30 Million |
CN¥333.31 Million ≈ $48.77 Million |
0.240x | -5.84% |
| 2012-12-31 | CN¥1.11 Billion ≈ $161.87 Million |
CN¥281.84 Million ≈ $41.24 Million |
0.255x | +41.29% |
| 2011-12-31 | CN¥936.39 Million ≈ $137.02 Million |
CN¥168.86 Million ≈ $24.71 Million |
0.180x | -17.63% |
| 2010-12-31 | CN¥624.85 Million ≈ $91.44 Million |
CN¥136.79 Million ≈ $20.02 Million |
0.219x | +8.98% |
| 2009-12-31 | CN¥539.75 Million ≈ $78.98 Million |
CN¥108.42 Million ≈ $15.87 Million |
0.201x | -- |
About Chengdu Kanghong Pharmaceuticals Group Co Ltd
Chengdu Kanghong Pharmaceutical Group Co., Ltd engages in the research, development, manufacture, and sale of pharmaceuticals and medical devices in China. It develops medicines for ophthalmic, neuropsychiatric, and others. The company was founded in 1996 and is headquartered in Chengdu, China.